ARHGAP11B Inhibitors

ARHGAP11B Inhibitors are primarily centered around the interference of the Rho GTPase signaling pathway. The basis of their action stems from the intimate association of ARHGAP11B with this particular pathway, where it functions as a GTPase-activating protein. For instance, compounds like Y-27632 and Fasudil are ROCK inhibitors. They modulate the Rho-associated kinase pathways, which are intrinsically tied to ARHGAP11B's functionality.

Another group of these compounds, like NSC 23766 and EHT 1864, target the GTPases directly or their binding partners. NSC 23766, for example, hinders Rac1 from binding to Rho GDP dissociation inhibitors (Rho GDIs). This specific action affects Rho GTPase activity, which ARHGAP11B can modulate. A similar strategy is seen with EHT 1864, which inhibits Rac family small GTPases. On a broader scale, compounds such as Statins (e.g., Lovastatin) influence the Rho GTPase pathway by hindering the prenylation of Rho proteins. Prenylation is a post-translational modification necessary for the correct localization and function of these proteins. By inhibiting this modification, the signaling activity of Rho GTPases can be disrupted.